阿贝西丽片在乳腺癌中的应用前景  

Application Prospects of Abemaciclib Tablets in Breast Cancer

作　　者：焦丽 温莲 高建国 张生军[2] 

机构地区：[1]延安大学医学院,陕西 延安 [2]延安大学附属医院,陕西 延安

出　　处：《临床医学进展》2023年第7期11002-11005,共4页Advances in Clinical Medicine

摘　　要：乳腺癌是目前影响人类生存和健康的重大疾病之一,占女性癌症发病率第1位,死亡率第2位。早期乳腺癌术后化疗是提高患者生存率的主要手段,但是随着乳腺癌进一步的发展和耐药性的增加,单用许多化疗药物已经很难满足疗效。通过搜索中国知网、万方、维普、PubMed数据库公开发表的乳腺癌术后治疗药物的临床研究文献,发现阿贝西丽片在乳腺癌的治疗中可发挥很大的作用,现对阿贝西丽片进行归纳总结。Breast cancer is currently one of the major diseases affecting human survival and health, account-ing for the 1st incidence of cancer in women and the 2nd in mortality. Postoperative chemotherapy for early-stage breast cancer is the main means to improve the survival rate of patients, but with the further development of breast cancer and the increase of drug resistance, it is difficult to meet the efficacy of many chemotherapy drugs alone. By searching the clinical research literature of postoperative treatment drugs for breast cancer published in CNKI, Wanfang, Weipu and PubMed databases, it was found that abemaciclib tablets can play a great role in the treatment of breast cancer, and abemaciclib tablets are summarized here.

关 键 词：乳腺癌 阿贝西丽片 CDK4/6抑制剂 淋巴结阳性 

分 类 号：R73[医药卫生—肿瘤]